Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 9/20/14  and contains information from public web pages and contributions from the ZoomInfo community.

Prof. Mark Kirkland

Wrong Prof. Mark Kirkland?

Chief Scientific Officer

Cytomatrix Pty Ltd
Local Address: Melbourne, Victoria, Australia
Company Description: Innovative biotechnology company, Cytomatrix, is currently involved in the development and commercialisation of powerful new medical therapies which are based on...   more
Background

Employment History

Board Memberships and Affiliations

  • Board Member
    Cell Care
  • Scientific Advisory Board Member
    Cell Care
  • Board Member
    PathCare Consulting Pathologists Director of Pathology at

Education

  • PhD
70 Total References
Web References
Cytomatrix chief scientific officer ...
cytomatrix.com.au, 20 Sept 2014 [cached]
Cytomatrix chief scientific officer Mark Kirkland.
...
Cytomatrix chief scientific officer Mark Kirkland said theirs was the first "off-the-shelf" system creating enough stem cells from an unmatched sample.
"The expander cells are only there temporarily to ­provide a boost or a support during the transplant, then disappear," Mr Kirkland said."That's enough to get the patient through the really dangerous period."It takes 26 days for double cord blood transplants to engraft, but with our product it will take 16 days, reducing the risk of infection."
...
Mark Kirkland, Chief Scientific Officer
According to Cytomatrix Chief ...
cytomatrix.com.au, 20 Sept 2014 [cached]
According to Cytomatrix Chief Executive Officer, Dr Mark Kirkland, "the problem is, there is a limited number of stem calls - which means the holy grail is to find ways of making more of them."
...
Dr Kirkland is enthusiastic about the value of the partnership model, believing that, "Cytomatrix's relationship with the AMCRC has been critical to getting the technology to where it is at the moment.
...
Mark Kirkland, Chief Scientific Officer
Mark ...
cytomatrix.com.au, 20 Sept 2014 [cached]
Mark Kirkland
...
Mark Kirkland Director & CSO
Mark is a Haematologist and stem cell researcher with a wide and varied experience in tissue banking, cGMP, commercial biotechnology and both public and private pathology.
Directors & Management Team | Cell Care
www.cellcare.com.au, 10 May 2014 [cached]
Mark Kirkland - Medical Director
...
Mark Kirkland
Email: .(JavaScript must be enabled to view this email address)
Biography
Mark Kirkland is Associate Professor at the Institute of Technology, Research and Innovation at Deakin University.
He is a specialist haematologist with more than 25 years research experience in the field of haemopoietic stem cell biology and 15 years experience as a clinical and laboratory haematologist.
A former Medical Director of Research for the Australian Red Cross Blood Service in Victoria, he has extensive experience in tissue banking, both public and private cord blood banking, and bone banking.
He was also a member of the committee that developed the Australian (NPAAC) Guidelines for Haemopoietic Stem Cells.
He is the Chief Scientific Officer of Cytomatrix Pty Ltd, a biotechnology company specialising in novel technologies for the growth and expansion of human adult stem cells.
...
Prof. Kirkland has been instrumental in the design and development of Cell Care's Clinical Trial program, and in particular has instigated the proposed Australia-wide trial in the use of cord blood to prevent the progression of type 1 diabetes.
...
Professor Mark Kirkland
Our Board of Directors | Cell Care Australia Cord Blood Storage Specialists
www.cellcareaustralia.com, 30 Aug 2011 [cached]
Mark Kirkland - Medical Director Email: mark.kirkland@cellcareaustralia.com
Mark Kirkland is Associate Professor at the Institute of Technology, Research and Innovation at Deakin University.
He is a specialist Haematologist with more than 25 years research experience in the field of haemopoietic stem cell biology and 15 years experience as a clinical and laboratory haematologist.
A former Medical Director of Research for the Australian Red Cross Blood Service in Victoria, he has extensive experience in tissue banking, both public and private cord blood banking, and bone banking.
He was also a member of the committee that developed the Australian (NPAAC) Guidelines for Haemopoietic Stem Cells.
He is the Chief Scientific Officer of Cytomatrix Pty Ltd, a biotechnology company specialising in novel technologies for the growth and expansion of human adult stem cells.
His current research interests include: Cord blood stem cell expansion Stem cell reprogramming, with particular emphasis on developing novel approaches to the production of insulin-producing cells and cardiac cells from cord blood stem cells, for the treatment of diabetes and heart disease, respectively, and on reprogramming to pluripotency ("iPS cells") The clinical use of cord blood in the treatment of cerebral palsy and type 1 diabetes. Prof. Kirkland has been instrumental in the design and development of Cell Care's Clinical Trial program, and in particular has instigated the proposed Australia-wide trial in the use of cord blood to prevent the progression of type 1 diabetes.
Other People with the name "Kirkland":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304